Most compounding pharmacies and compounded tirzepatide dosing guides default to this ratio for the 30 mg vial
Importantly, all three were due to classic myocarditis (caused by infection of a bacteria/virus) and not due to the vaccine
However, its important to note that there is no FDA-approved version of this medication, so no clinical trial data exists to substantiate the risk profile
UK guidelines, primarily from NICE Clinical Knowledge Summary and the British National Formulary (BNF), provide evidence-based recommendations for treatment
The feedback form on this page can be used to report content that is not accurate, up-to-date or questionable in any manner
Xiao, B., Xu, Z., Viennois, E., Zhang, Y., Zhang, Z., Zhang, M., Han, M